BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 24392978)

  • 1. Subgroups: time to go back to basic statistical principles?
    Keene ON; Garrett AD
    J Biopharm Stat; 2014; 24(1):58-71. PubMed ID: 24392978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An overview of statistical and regulatory issues in the planning, analysis, and interpretation of subgroup analyses in confirmatory clinical trials.
    Hemmings R
    J Biopharm Stat; 2014; 24(1):4-18. PubMed ID: 24392975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of statistical planning to address subgroups in confirmatory clinical trials.
    Koch GG; Schwartz TA
    J Biopharm Stat; 2014; 24(1):72-93. PubMed ID: 24392979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Bayesian approach to subgroup identification.
    Berger JO; Wang X; Shen L
    J Biopharm Stat; 2014; 24(1):110-29. PubMed ID: 24392981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multiplicity of inferences in clinical trials: adjustment methods, clinical interpretation issues].
    Jouan-Flahault C; Casset-Semanaz F; Minini P
    Med Sci (Paris); 2004 Feb; 20(2):231-5. PubMed ID: 14997445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p-value adjustments for subgroup analyses.
    Bristol DR
    J Biopharm Stat; 1997 May; 7(2):313-21; discussion 323-31. PubMed ID: 9136072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interpretation of subgroup effects in published trials.
    Hancock MJ; Kjaer P; Korsholm L; Kent P
    Phys Ther; 2013 Jun; 93(6):852-9. PubMed ID: 23431217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. General guidance on exploratory and confirmatory subgroup analysis in late-stage clinical trials.
    Dmitrienko A; Muysers C; Fritsch A; Lipkovich I
    J Biopharm Stat; 2016; 26(1):71-98. PubMed ID: 26366479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Guest editors' note: Special issue on subgroup analysis in clinical trials.
    Wang SJ; Dmitrienko A
    J Biopharm Stat; 2014; 24(1):1-3. PubMed ID: 24392974
    [No Abstract]   [Full Text] [Related]  

  • 10. A flexible strategy for testing subgroups and overall population.
    Alosh M; Huque MF
    Stat Med; 2009 Jan; 28(1):3-23. PubMed ID: 18985704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliably basing conclusions on subgroups of randomized clinical trials.
    Koch A; Framke T
    J Biopharm Stat; 2014; 24(1):42-57. PubMed ID: 24392977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Qualitative consistency of treatment effects in multiregional clinical trials.
    Tanaka Y; Li G; Wang Y; Chen J
    J Biopharm Stat; 2012 Sep; 22(5):988-1000. PubMed ID: 22946945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Test for the consistency of noninferiority from multiple clinical trials.
    Yan X; Wang MC; Su X
    J Biopharm Stat; 2007; 17(2):265-78. PubMed ID: 17365223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The statistical challenges in clinical studies. Preface.
    Zhou XH; Johnson LL
    Stat Med; 2012 Mar; 31(7):601. PubMed ID: 22392624
    [No Abstract]   [Full Text] [Related]  

  • 15. Statistical considerations on design and analysis of bridging and multiregional clinical trials.
    Tsong Y
    J Biopharm Stat; 2012 Sep; 22(5):1078-80. PubMed ID: 22946952
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiplicity considerations for subgroup analysis subject to consistency constraint.
    Alosh M; Huque MF
    Biom J; 2013 May; 55(3):444-62. PubMed ID: 23585158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The advantages and disadvantages of adaptive designs for clinical trials.
    Bauer P; Brannath W
    Drug Discov Today; 2004 Apr; 9(8):351-7. PubMed ID: 15081962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing vaccine efficacy in influenza clinical trials: challenges and difficulties.
    Dewe W; Benoit A; Legrand C
    Expert Rev Clin Pharmacol; 2013 Jul; 6(4):403-11. PubMed ID: 23927668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of the limitations of statistical analysis of treatment outcomes used in periodontal research.
    Galgut PN
    J Int Acad Periodontol; 2003 Oct; 5(4):92-7. PubMed ID: 14604057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of ethnic minorities and gender effects in clinical trials: opportunities lost and rediscovered.
    Moyé LA; Powell JH
    J Natl Med Assoc; 2001 Dec; 93(12 Suppl):29S-34S. PubMed ID: 11798062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.